Each Division << National Cancer Center Research Institute
About National Cancer Center to HOME to National Cancer Center Research Institute
font size| large | normal | small |
HOME > National Cancer Center Research Institute > Publication & Reports > List of Papers Published This Month

List of Papers Published This Month

Group for Development of Molecular Diagnostics and Individualized Therapy
1. Division of Epigenomics
2. Division of Genome Biology
Group for Translational Research
3. Division of Cancer Pathophysiology

1. Division of Epigenomics

1. Hattori N, Ushijima T. Compendium of aberrant DNA methylation and histone modifications in cancer. Biochem Biophys Res Commun, 455:3-9, 2014

2. Liu Z, Zhang J, Gao Y, Pei L, Zhou J, Gu L, Zhang L, Zhu B, Hattori N, Ji J, Yuasa Y, Kim W, Ushijima T, Shi H, Deng D. Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis. Clin Cancer Res, 20:4598-4612, 2014

3. Ueda Y, Ando T, Nanjo S, Ushijima T, Sugiyama T. DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis. Dig Dis Sci, 59:2444-5451, 2014

4. Yamada M, Fukagawa T, Nakajima T, Asada K, Sekine S, Yamashita S, Okochi-Takada E, Taniguchi H, Kushima R, Oda I, Saito Y, Ushijima T, Katai H. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1. Gastric Cancer, 17:750-756, 2014

2. Division of Genome Biology

5. Oike T, Komachi M, Ogiwara H, Amornwichet N, Saitoh Y, Torikai K, Kubo N, Nakano T, Kohno T. C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe. Radiother Oncol, 111:222-227, 2014

6. Oike T, Ogiwara H, Amornwichet N, Nakano T, Kohno T. Chromatin-regulating proteins as targets for cancer therapy. J Radiat Res, 55:613-628, 2014

7. Oike T, Ogiwara H, Nakano T, Kohno T. Proposal for a synthetic lethality therapy using the paralog dependence of cancer cells--response. Cancer Res, 74:4948-4949, 2014

8. Saito M, Ishigame T, Tsuta K, Kumamoto K, Imai T, Kohno T. A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis. Carcinogenesis, 35:2452-2456, 2014

3. Division of Cancer Pathophysiology

9. Harayama N, Kayano T, Moriya T, Kitamura N, Shibuya I, Tanaka-Yamamoto K, Uezono Y, Ueta Y, Sata T. Analysis of G-protein-activated inward rectifying K+ (GIRK) channel currents upon GABAB receptor activation in rat supraoptic neurons. Brain Res, 1591:1-13, 2014

10. Kono T, Kaneko A, Matsumoto C, Miyagi C, Ohbuchi K, Mizuhara Y, Miyano K, Uezono Y. Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin E2 production in human oral keratinocytes. Integr Cancer Ther, 13:435-445, 2014

11. Mizuno K, Kono T, Suzuki Y, Miyagi C, Omiya Y, Miyano K, Kase Y, Uezono Y. Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat. J Pharmacol Sci, 125:91-98, 2014

12. Yokoyama T, Minami K, Terawaki K, Miyano K, Ogata J, Maruyama T, Takeuchi M, Uezono Y, Ueta Y. Kisspeptin-10 potentiates miniature excitatory postsynaptic currents in the rat supraoptic nucleus. Brain Res, 1583:45-54, 2014

to this page top